Thus, the role of the GP Ia/IIa polymorphisms for the prognosis of cardiovascular disease remains a matter of debate, but might help to individualize risk-based strategies for secondary prophylaxis especially in high-risk patients. Here, ITGA2 is linked to cardiovascular disorder.